Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study (RTSS-SMC)
Seasonal Vaccination With the RTS,S/AS01 Malaria Vaccine Given With or Without Seasonal Malaria Chemoprevention: Extension of a Randomised, Double-blind Phase 3 Trial Until Children Reach the Age of Five Years
Sponsor: Institut de Recherche en Sciences de la Sante, Burkina Faso
A PHASE3 clinical study on Child, Only and Malaria,Falciparum, this trial is completed. The trial is conducted by Institut de Recherche en Sciences de la Sante, Burkina Faso and has accumulated 9 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
9 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Mar 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Feb 2023 — Mar 2023 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Oct 2021 — Feb 2023 [monthly]
Active Not Recruiting PHASE3
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
Status: Not Yet Recruiting → Active Not Recruiting
-
Apr 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut de Recherche en Sciences de la Sante, Burkina Faso
- London School of Hygiene and Tropical Medicine
- Malaria Research and Training Center, Bamako, Mali
For direct contact, visit the study record on ClinicalTrials.gov .